Inhaled Asbestos Fibers Induce p53 Expression in the Rat Lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 4, 1997, Pages 479-485

  Mishra, Anil ^a   Liu, Jing Yao ^a   Brody, Arnold R ^a   Morris, Gilbert F ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; RODENTIA;

ASBESTOS; CYCLINE; MESSENGER RNA;

ANIMAL; ARTICLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TUMOR SUPPRESSOR GENE;

ADMINISTRATION, INHALATION; ANIMALS; ASBESTOS; GENE EXPRESSION REGULATION; GENES, P53; LUNG; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0031115162     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.4.9115760     Document Type: Article

References (66)

1. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.
2. Donehower, L. A., and A. Bradley. 1993. The tumor suppressor p53. Biochim. Biophys. Acta 1155:181-205.
3. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but are susceptible to spontaneous tumors. Nature 356:215-221.
4. Sah, V. P., L. D. Attardi, G. J. Mulligan, B. O. Williams, R. T. Bronson, and T. Jacks. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nature Genetics 10(2):175-180.
5. Chang, L. Y., L. H. Overby, A. R. Brody, and J. D. Crapo. 1988. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am. J. Pathol. 131:156-170.
6. Brody, A. R., and L. H. Overby. 1989. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestos-exposed rats. Am. J. Pathol. 134:133-140.
7. Warheit, D. B., K. E. Driscoll, G. Oberdoerster, C. Walker, M. Kuschner, and T. W. Hesterberg. 1995. Contemporary issues in fiber toxicology. Fundam. Appl. Toxicol. 25:171-183.
8. McGavran, P. D., C. J. Butterick, and A. R. Brody. 1990. Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchiolar-alveolar regions of normal and complement-deficient mice after inhalation of chrysotile asbestos. J. Environ. Pathol. Toxicol. Oncol. 6:377-388.
9. Rom, W. N., W. D. Travis, and A. R. Brody. 1991. Cellular and molecular basis of the asbestos-related diseases. Am. Rev. Respir. Dis. 143(2):408-422.
10. Driscoll, K. E., J. K. Maurer, J. Higgins, and J. Poynter. 1995. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. J. Toxicol. Environ. Health 46:155-169.
11. Liu, J.-Y., G. F. Morris, W.-H. Lei, M. Corti, and A. R. Brody. 1996. Upregulated expression of transforming growth factor alpha in the bronchiolar-alveolar duct regions of asbestos-exposed rats. Am. J. Pathol. 149:205-217.
12. Perdue, T. D., and A. R. Brody. 1994. Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J. Histochem. Cyyochem. 42(8):1061-1070.
13. Morris, G. F., J.-Y. Liu, W.-H. Lei, and A. R. Brody. 1996. Expression of genes coding for growth factors in experimental pneumoconiosis. Chest 109:45S-49S.
14. Coin, P. G., V. L. Roggli, and A. R. Brody. 1992. Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ. Res. 58(1):97-116.
15. Coin, P. G., A. Osornio-Vargas, L. Moore, and A. R. Brody. 1996. Three consecutive exposures to chrysotile asbestos induces prolonged cell proliferation and a fibrogenic lesion of the alveolar duct walls. Am. J. Respir. Crit. Care Med. (In press)
16. Simeonova, P. P., and M. I. Luster. 1995. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12(6):676-683.
17. Quinlan, T. R., J. P. Marsh, Y. M. W. Janssen, P. A. Borm, and B. T. Mossman. 1994. Oxygen radicals and asbestos-mediated disease. Environ. Health Perspect. 102(Suppl. 10):107-110.
18. Dong, H., A. Buard, A. Renier, F. Levy, L. Saint-Etienne, and M. C. Jaurand. 1994. Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat plerual mesothelial cells in vitro. Carcinogenesis 15(6):1251-1255.
19. Schapira, R. M., A. J. Ghio, R. M. Effros, J. Morrisey, C. A. Dawson, and A. D. Hacker. 1994. Hydroxyl radicals are formed in the rat lung after asbestos instillation in vivo. Am. J. Respir. Cell Mol. Biol. 10(5):573-579.
20. Janssen, Y. M., N. H. Heintz, J. P. Marsh, P. J. A. Borm, and B. T. Mossman. 1992. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J. Biol. Chem. 267(15):10625-10630.
21. Heintz, N. H., Y. M. Janssen, and B. T. Mossman. 1993. Persistant induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA 90: 3299-3303.
22. Janssen, Y. M., N. H. Heintz, and B. T. Mossman. 1995. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res. 15:2085-2089.
23. Hart, G. A., L. M. Kathman, and T. W. Hesterberg. 1994. In vitro cytotoxicity of asbestos and man-made vitreous fibers: roles of fiber length, diameter and composition. Carcinogenesis 15(5):971-977.
24. Hardy, J. A., and A. E. Aust. 1995. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16(2):319-325.
25. Kamp, D. W., V. A. Israbian, S. E. Preusen, C. X. Zhang, and S. A. Weitzman. 1995. Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals. Am. J. Physiol. 268(3, Pt. 1):L471-L480.
26. Lund, L. G., and A. E. Aust. 1992. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in phi X174 RF1 DNA. Carcinogenesis 13(4):637-642.
27. Gotz, C., and M. Montenarh. 1996. p53: DNA damage, DNA repair, and apoptosis. Rev. Physiol. Biochem. Pharmacol. 127:65-95.
28. Prelich, G., M. Kostura, D. R. Marshak, M. B. Mathews, and B. Stillman. 1987. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 326:471-175.
29. Shivji, M. K. K., M. K. Kenny, and R. D. Wood. 1992. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69:367-374.
30. Morris, G. F., J. R. Bischoff, and M. B. Mathews. 1996. Transcriptional activation of the human proliferating cell nuclear antigen promoter by p53. Proc. Natl. Acad. Sci. USA 93:895-899.
31. Shivakumar, C. V., D. R. Brown, S. Deb, and S. P. Deb. 1995. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol. Cell. Biol. 15:6785-6793.
32. Shi, S. R., S. A. Iama, L. Young, R. J. Cote, and C. R. Taylor. 1995. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J. Histochem. Cytochem. 43:193-201.
33. Morris, G. F., and M. B. Mathews. 1991. The adenovirus EIA transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J. Virol. 65(12):6397-6406.
34. Matsumoto, K., T. Moriuchi, T. Koji, and P. Nakane. 1987. Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA)/cyclin. EMBO J. 6:637-642.
35. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
36. Bravo, R., and H. Macdonald-Bravo. 1987. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J. Cell Biol. 105(4):1549-1554.
37. Brody, A. R. 1993. Asbestos-induced lung disease. Environ. Health Perspect. 100:21-30.
38. Hesterberg, T. W., W. C. Miiller, E. E. McConnell, J. Chevalier, J. G. Hadley, and D. M. Bernstein. 1993. Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Fundam. Appl. Toxicol. 20(4):464-476.
39. Horikoshi, N., W. C. Miiller, E. E. McConnell, J. Chevalier, J. G. Hadley, and D. M. Bernstein. 1995. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol. Cell. Biol. 15: 227-234.
40. Liu, X., and A. J. Berk. 1995. Reversal of in vitro p53 squelching by both TFIIB and TFIID. Mol. Cell Biol. 15(11):6474-6478.
41. Harper, J. W., G. R. Adami, N. Wei, K. Keyomars, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
42. El-Deiry, W., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
43. Luo, Y., J. Hurwitz, and J. Massague. 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375(6527): 159-161.
44. Waga, S., G. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
45. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80(2):293-299.
46. Mayall, F. G., H. Goddard, and A. R. Gibbs. 1993. The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomas. Histopathology 22(4):383-386.
47. Nuorva, K., R. Makitaro, F., Huhti, D. Kamel, K. Vahakangas, R. Bloigu, Y. Soini, and P. Paakko. 1994. p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke. Am. J. Respir. Crit. Care Med. 150(2):528-533.
48. Guinee, D. G., Jr., W. D. Travis, G. E. Trivers, V. M. De Benedetti, H. Cawley, J. A. Welsh, W. P. Bennett, J. Jett, T. V. Colby, H. Tazelaar, S. L. Abbondanzo, P. Pairolero, V. Trastek, N. E. Caporaso, L. A. Liotta, and C. C. Harris. 1995. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis 16(5):993-1002.
49. Bui, K. C., S. Buckley, F. Wu, B. Uhal, I. Joshi, J. Liu, M. Hussain, I. Makhoul, and D. Warburton. 1995. Induction of A- and D-type cyclins and cdc2 kinase activity during recovery from short-term hyperoxic lung injury. Am. J. Physiol. 268(4, Pt. 1):L625-L635.
50. Walker, C. J. Robertson, M. W. Myskow, N. Pendleton, and G. R. Dixon. 1994. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer 70(2):297-303.
51. Zsengeller, Z. K., S. E. Wert, W. M. Hull, X. Hu, S. Yei, B. C. Trapnell, and J. A. Whitsett. 1995. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6(4):457-467.
52. Monobe, Y., and T. Manabe. 1995. Morphological changes and proliferative activity of alveolar epithelium in mouse lungs treated with urethan. Virchows Arch. 425(6):583-588.
53. Almendral, J. M., D. Huebsch, P. A. Blundell, H. Macdonald-Bravo, and R. Bravo. 1987. Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc. Natl. Acad. Sci. USA 84: 1575-1579.
54. Jaskulski, D., C. Gatti, S. Travali, B. Calabretta, and R. Baserga. 1988. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J. Biol. Chem. 263:10175-10179.
55. Zerler, B., R. J. Roberts, M. B. Mathews, and E. Moran. 1987. Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol. Cell. Biol. 7:821-829.
56. Moore, K. S., S. K. Sullivan, E. M. Tan, and M. B. Prystowsky. 1987. Proliferating cell nuclear antigen/cyclin is an interleukin 2-responsive gene. J. Biol. Chem. 262(18):8447-8450.
57. Janssen, Y. M. W., N. H. Heintz, J. P. Marsh, P. J. A. Borm, and B. T. Mossman. 1994. Induction of c-fos and c-jun in target cells of the lung and pleura by carcinogenic fibers. Am. J. Respir Cell Mol. Biol. 11:522-530.
58. Hai, T. W., F. Liu, W. J. Coukos, and M. R. Green. 1989. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3(12B):2083-2090.
59. Huang, D., P. M. Shipman-Appasamy, D. J. Orten, S. H. Hinrichs, and M. B. Prystowsky. 1994. Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes. Mol. Cell. Biol. 14(6):4233-4243.
60. Labrie, C. B. H. Lee, and M. B. Mathews. 1995. Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Res. 23(18):3732-3741.
61. Li, R., S. Waga, G. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537.
62. Cells, J. E., and P. Madsen. 1986. Increased nuclear cyclin/PCNA antigen staining on non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett. 209:277-283.
63. Dong, H. Y., A. Buard, F. Levy, A. Renier, F. Laval, and M. C. Jaurand. 1995. Synthesis of poly(ADP-ribose) in asbestos treated rat pleural mesothelial cells in culture. Mutat. Res. 331(2):197-204.
64. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
65. Smith, M. L., I. T. Chen, Q. Zhan, I. Bae, C. Y. Chen, T. M. Gilmer, M. B. Kastan, P. M. O'Connor, and A. J. Fornace, Jr. 1994. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266:1376-1380.
66. Shin, T. H., A. J. Paterson, and J. E. Kudlow. 1995. p53 stimulates transcription from the transforming growth factor alpha promoter: a potential growth-stimulatory role for p53. Mol. Cell. Biol. 15:4694-1701.